PaP Score — Palliative Prognostic Score

ورودی‌های بالینی بیمار

حداقل ۵۰۰ — حداکثر ۱۰۰۰۰۰

حداقل ۰ — حداکثر ۱۰۰

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
pap score
—points
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • Group A0–5.5
  • Group B5.5–11
  • Group C11–17.5
Direct Clinical Answer

The PaP Score — Palliative Prognostic Score calculates staging malignant disease, estimating overall survival, and assessing chemotherapy tolerability. Key inputs include dyspnea. Scores guide adjusting systemic antineoplastic regimens, planning supportive palliative measures, or targeted monitoring. This standardized assessment improves clinical decision safety and bedside patient management.

Clinical Guidelines & Evidence

The PaP score estimates 30-day survival probability in advanced solid-tumor patients from 6 variables (dyspnea, anorexia, KPS, clinician prediction, WBC, lymphocyte %). Total 0-17.5.

Clinical Indication

The PaP Score — Palliative Prognostic Score is indicated for bedside clinical practice to support The PaP score estimates 30-day survival probability in advanced solid-tumor patients from 6 variables (dyspnea, anorexia, KPS, clinician prediction, WBC, lymphocyte %). Total 0-17.5.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Patients with solid tumors or hematologic malignancies undergoing staging, systemic therapy tolerability assessment, or prognostic stratification. Clinical application is indicated across Medical oncology clinics, chemotherapy infusion suites, inpatient oncology services, and palliative care.

Limitations & Contraindications

Prognostic indices provide statistical cohort survival estimates and must not replace individualized patient goals of care.

Clinical Pearls & Action Plan

Standardized functional performance status (ECOG or Karnofsky) is an independent determinant of chemotherapy tolerance and survival.

Formula & Variables:

PaP = dyspnea (0/1.0) + anorexia (0/1.5) + KPS (>=50: 0; 30-40: 0; 10-20: 2.5) + clinician prediction of survival in weeks (>12: 0; 11-12: 2.0; 9-10: 2.5; 7-8: 2.5; 5-6: 4.5; 3-4: 6.0; 1-2: 8.5) + WBC (4800-8500: 0; 8501-11000: 0.5; >11000: 1.5) + lymphocytes % (20-40: 0; 12-19.9: 1.0; <12: 2.5). Range 0-17.5.

Input Parameters

NameTypeRequiredDescription
dyspneabooleanYesDyspnea present
anorexiabooleanYesAnorexia present
kpsintegerYesKarnofsky performance status (%)
cps_weeksintegerYesClinician prediction of survival (weeks)
wbcfloatYesTotal white blood count (cells/mm3)
lymphocyte_pctfloatYesLymphocyte percentage (%)

Score Interpretation & Guidance

RangeStageDescription
0–5.5Group AGroup A (0-5.5): >70% 30-day survival
5.5–11Group BGroup B (5.6-11.0): 30-70% 30-day survival
11–17.5Group CGroup C (11.1-17.5): <30% 30-day survival

Evidence-Based References (EBM)

  • Pirovano M, Maltoni M, Nanni O, et al. A new palliative prognostic score: a first step for the staging of terminally ill cancer patients. J Pain Symptom Manage. 1999;17(4):231-239.
  • Maltoni M, Nanni O, Pirovano M, et al. Successful validation of the palliative prognostic score in terminally ill cancer patients. J Pain Symptom Manage. 1999;17(4):240-247.

Related calculators